Other Specialty Therapeutics

Clearer oversight. Greater efficiency. Lower costs. Minimized risks.

Clearer oversight. Greater efficiency. Lower costs. Minimised risks.

Developed through 30+ years’ global industry experience is empowering all kinds of trial teams to make better-informed decisions and streamline efficiency.

Deep understanding across multiple disciplines

Outside of our full service offering, we can also support other specialty therapeutic experience in the following areas with our Consulting and FSP services:

Autoimmune Disease

Clinical Pharmacology

Congenital Disorders

Endocrine/Metabolic

Genitourinary

Hepatobilary

Musculoskeletal

Women’s Health

Our expert’s deeper level of understanding across multiple disciplines with complex study designs, innovative protocols, advanced therapies, or specialty populations has provided sponsors with trial success.

How can we support your next project?

Examples of Personalised medicine designs

Umbrella trials

Basket trials

Interaction designs

Enrichment design

Adaptive enrichment designs

Marker strategy designs

Platform trials

Insights

Utilising CROs for Effective Planning and Execution of Clinical Development

At the recent BioStock Summit in Lund, Aixial’s experts, Ashley Hunter, Senior Director of Clinical Operations and Head of Strategic Development & Delivery, and Anna Yanaeva, Senior Director for Business Development, led an engaging discussion on the importance of “Utilising CROs for Effective Planning and Execution of Clinical Development”.

Writings with molecules and standards as main characters

Clear communication is essential to drug development. At Aixial Group, our experienced medical writers know how to turn complex scientific data into clear, accurate documents. From regulatory protocols to scientific publications, they ensure clarity and compliance at every stage.

Clinical trials – when digital becomes critical

Digitalisation — Clinical trials are essential research studies evaluating medical intervention safety and efficacy, with varying designs and phases aimed at understanding treatment effects and patient experiences…

Atomising cancer

Breakthrough — Radiopharmaceutical therapy represents a novel approach to treating cancer, utilising radioactive atoms to target and destroy malignant cells with precision, without affecting the patient’s healthy tissues. A field in which Aixial has emerged as a pioneer.

Training and upskilling are part of our genes

Talents — The world of life sciences is vast and constantly evolving. It’s not enough to follow trends: you have to anticipate them, and to do that you need to bring together the best specialists. At Aixial Group, Stéphane Thérèse is well aware of this.

OTHER WAYS WE SUPPORT YOU

Helping you succeed in your project

Oncology

Rare diseases

Cell & gene therapy